Back
Add Comment
Topics
Vote
Results
clinical endpoint
occurrence or absence of disease, symptom, sign or laboratory abnormality constituting a target outcome in clinical research trials
--Agreed Upon Solutions

The discussion does not exist would you like to add the first comment?

anonymous